Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB vs OS-TAPB in Emergency Abdominal Surgery
NCT06448299Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Jun 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Postoperative morphine consumption at 24 hours. Started Jun 2024; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06448299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06448299.